LG Chem

051910 · KOSPI · South Korea

Public Market Listing

051910KOSPI

KOSPI primary exchange listing

Live quotes, historical charts, and market capitalization for LG Chem are available on Yahoo Finance.

View quote & market cap on Yahoo Finance ↗

External market data link · No third-party exchange redistribution

Assets

(4 total)
4Total Assets
0Approved
2Phase 3 / Filed
2Phase 1–2 / Early
4Diseases
Quick filter:
Showing 4 of 4 assets
Target & Modality
Phase 3
HBV polymerase (reverse transcriptase)Small molecule
Chronic Hepatitis B
Gemigliptin(Zemiglo)
Phase 3
DPP-4Small molecule
Type 2 Diabetes
Phase 2
MC4RSmall molecule
Hypothalamic Obesity
Phase 1
LILRB family receptorMonoclonal antibody
Non-Small Cell Lung Cancer

Upcoming events

(1 total)

Estimated primary-completion dates from ClinicalTrials.gov and expected earnings reports. These are registry estimates, never confirmed readout dates; they can move as trials progress.

Add these trial readouts to your calendar: Apple or Outlook · Google Calendar · .ics link. The calendar updates when a registry date moves.

2028 (1)
April 2028 (1)
bivamelagonPhase 2Hypothalamic Obesity
Est. primary completion 2028-04-15 · NCT07156578 · CT.gov ↗
What to watch

See the full readout calendar ↗

Financial reports

Annual history (1 year)

PeriodRevenueR&DCash & equiv.Net loss / qtrFiling
2025-FY$32.3B———report ↗